BIO-RAD LABORATORIES-A (BIO) Institutional Shareholders

BIO-RAD LABORATORIES-A (BIO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $5.28B in BIO holdings during the latest filing period.

First Eagle U.S. Value is currently the largest disclosed institutional shareholder of BIO tracked by InsiderSet, reporting ownership valued at approximately $725.52M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $847.15M, representing an estimated gain of +16.76% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 52% of the total disclosed BIO value among the investors covered in this analysis. Major shareholders include First Eagle U.S. Value, Blackrock, Inc., Dimensional Fund Advisors Lp, and several other long-term asset managers with concentrated positions in BIO-RAD LABORATORIES-A (BIO).

This page ranks the largest institutional BIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

381

Total Reported Value

$5.28B

Largest Holder

First Eagle U.S. Value

Largest Position

$725.52M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

53

Funds Exiting Positions

0

Page 1 of 8
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
First Eagle U.S. ValueJean-Marie Eveillard0.96%2,602,772$725,522,734$847,150,231+$121,627,497+16.76%
Blackrock, Inc.0.01%1,680,060$468,316,523$546,825,929+$78,509,406+16.76%
Dimensional Fund Advisors Lp0.06%1,089,323$303,636,693$354,552,850+$50,916,157+16.77%
Vanguard Capital Management Llc0.01%831,165$231,687,244$270,527,584+$38,840,340+16.76%
Vanguard Portfolio Management Llc0.01%829,186$231,135,598$269,883,459+$38,747,861+16.76%
Ariel Appreciation FundJohn W. Rogers Jr.2.45%785,961$219,086,629$255,814,586+$36,727,957+16.76%
Earnest Partners Llc0.68%588,731$164,108,766$191,620,166+$27,511,400+16.76%
State Street Corp0.01%559,570$155,980,138$182,128,844+$26,148,706+16.76%
Capital World Investors0.02%450,000$125,437,500$146,466,000+$21,028,500+16.76%
Bank Of America Corp0.01%444,957$124,031,764$144,824,604+$20,792,840+16.76%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.02%426,038$118,758,094$138,666,848+$19,908,754+16.76%
First Pacific Advisors, Lp1.59%407,358$113,551,043$132,586,882+$19,035,839+16.76%
Massachusetts Financial Services Co0.04%396,150$110,422,710$128,938,902+$18,516,192+16.77%
Capital Research Global Investors0.02%385,579$107,480,146$125,498,253+$18,018,107+16.76%
Geode Capital Management, Llc0.01%364,682$101,678,457$118,696,697+$17,018,240+16.74%
Ubs Group Ag0.02%354,365$98,779,244$115,338,720+$16,559,476+16.76%
Sei Investments Co0.07%287,912$80,260,574$93,709,598+$13,449,024+16.76%
Barclays Plc0.03%278,835$77,725,256$90,755,216+$13,029,960+16.76%
Morgan Stanley0.00%273,931$76,358,666$89,159,062+$12,800,396+16.76%
Assenagon Asset Management S.A.0.09%233,227$68,477,779$75,910,724+$7,432,945+10.85%
Deerfield Management Company, L.P.0.74%226,070$63,017,013$73,581,264+$10,564,251+16.76%
Northern Trust Corp0.01%218,497$60,906,040$71,116,404+$10,210,364+16.76%
Nomura Holdings Inc0.50%217,342$60,584,083$70,740,474+$10,156,391+16.76%
Charles Schwab Investment Management Inc0.01%196,558$54,790,543$63,975,698+$9,185,155+16.76%
Mawer Investment Management Ltd.0.34%188,784$52,623,540$61,445,416+$8,821,876+16.76%
Franklin Resources Inc0.01%170,354$47,486,178$55,446,820+$7,960,642+16.76%
Longleaf PartnersMason Hawkins2.23%162,804$45,381,615$52,989,446+$7,607,831+16.76%
Gotham Asset Management, Llc0.13%152,384$42,477,040$49,597,944+$7,120,904+16.76%
Citadel Advisors Llc0.03%148,669$41,441,484$48,388,786+$6,947,302+16.76%
Freestone Grove Partners Lp0.30%147,605$41,144,894$48,042,475+$6,897,581+16.76%
Bank Of New York Mellon Corp0.01%126,856$35,361,235$41,289,091+$5,927,856+16.76%
Mangrove Partners Im, Llc2.86%126,853$35,360,274$41,288,114+$5,927,840+16.76%
Cibc Bancorp Usa Inc.0.05%120,120$33,483,450$39,096,658+$5,613,208+16.76%
Fisher Asset Management, Llc0.01%118,683$33,082,885$38,628,943+$5,546,058+16.76%
Boston Trust Walden Corp0.25%111,167$32,639,743$36,182,635+$3,542,892+10.85%
Vanguard Fiduciary Trust Co0.01%113,639$31,676,871$36,987,222+$5,310,351+16.76%
Allianz Asset Management Gmbh0.04%110,241$30,729,679$35,881,241+$5,151,562+16.76%
Federated Hermes, Inc.0.05%109,895$30,633,233$35,768,625+$5,135,392+16.76%
Envestnet Asset Management Inc0.01%105,333$29,361,526$34,283,785+$4,922,259+16.76%
Manufacturers Life Insurance Company, The0.02%99,720$27,796,950$32,456,866+$4,659,916+16.76%
Tikvah Management Llc8.45%97,834$27,271,228$31,843,010+$4,571,782+16.76%
Hound Partners, Llc3.44%97,724$27,240,565$31,807,208+$4,566,643+16.76%
Aqr Capital Management Llc0.01%94,549$26,027,466$30,773,809+$4,746,343+18.24%
Jne Partners Llp10.50%92,100$25,672,875$29,976,708+$4,303,833+16.76%
Ing Groep Nv0.15%90,000$25,087,500$29,293,200+$4,205,700+16.76%
National Bank Of Canada0.03%90,000$25,087,500$29,293,200+$4,205,700+16.76%
Allspring Global Investments Holdings, Llc0.04%85,965$23,929,217$27,979,888+$4,050,671+16.93%
Qvidtvm Management Llc28.68%83,732$23,340,295$27,253,091+$3,912,796+16.76%
Exchange Traded Concepts, Llc0.10%72,116$21,173,979$23,472,316+$2,298,337+10.85%
Hosking Partners Llp0.69%69,009$19,236,259$22,461,049+$3,224,790+16.76%

Frequently asked questions about BIO

  • Who owns the most BIO stock?

    The largest holders of BIO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIO-RAD LABORATORIES-A (BIO).

  • Is BIO widely held by superinvestors?

    Many widely followed stocks like BIO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BIO is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.